Long-term Risks of Recurrence After Hospital Discharge for Acute Lower Gastrointestinal Bleeding: A Large Nationwide Cohort Study

• Published in: Clinical gastroenterology and hepatology Vol. 21; no. 13; pp. 3258 - 3269.e6
• Main Authors: Sato, Yoshinori, Aoki, Tomonori, Sadashima, Eiji, Nakamoto, Yusuke, Kobayashi, Katsumasa, Yamauchi, Atsushi, Yamada, Atsuo, Omori, Jun, Ikeya, Takashi, Aoyama, Taiki, Tominaga, Naoyuki, Kishino, Takaaki, Ishii, Naoki, Sawada, Tsunaki, Murata, Masaki, Takao, Akinari, Mizukami, Kazuhiro, Kinjo, Ken, Fujimori, Shunji, Uotani, Takahiro, Fujita, Minoru, Sato, Hiroki, Suzuki, Sho, Narasaka, Toshiaki, Hayasaka, Junnosuke, Funabiki, Tomohiro, Kinjo, Yuzuru, Mizuki, Akira, Kiyotoki, Shu, Mikami, Tatsuya, Gushima, Ryosuke, Fujii, Hiroyuki, Fuyuno, Yuta, Gunji, Naohiko, Toya, Yosuke, Narimatsu, Kazuyuki, Manabe, Noriaki, Nagaike, Koji, Kinjo, Tetsu, Sumida, Yorinobu, Funakoshi, Sadahiro, Kobayashi, Kiyonori, Matsuhashi, Tamotsu, Komaki, Yuga, Maehata, Tadateru, Tateishi, Keisuke, Kaise, Mitsuru, Nagata, Naoyoshi
• Format: Journal Article
• Language: English
• Published: United States 01-12-2023
• Subjects: Acute Disease; Cohort Studies; Diverticular Diseases; Gastrointestinal Hemorrhage - diagnosis; Gastrointestinal Hemorrhage - epidemiology; Gastrointestinal Hemorrhage - etiology; Hemostasis, Endoscopic; Hospitals; Humans; Patient Discharge; Recurrence; Retrospective Studies; Risk Factors; Thienopyridines; Risk Factor; Acute Lower Gastrointestinal Hemorrhage; Endoscopic Diagnosis; Long-term Rebleeding
• ISSN: 1542-3565; 1542-7714
• DOI: 10.1016/j.cgh.2023.05.021

Currently, large, nationwide, long-term follow-up data on acute lower gastrointestinal bleeding (ALGIB) are scarce. We investigated long-term risks of recurrence after hospital discharge for ALGIB using a large multicenter dataset.
We retrospectively analyzed 5048 patients who were urgently hospitalized for ALGIB at 49 hospitals across Japan (CODE BLUE-J study). Risk factors for the long-term recurrence of ALGIB were analyzed by using competing risk analysis, treating death without rebleeding as a competing risk.
Rebleeding occurred in 1304 patients (25.8%) during a mean follow-up period of 31 months. The cumulative incidences of rebleeding at 1 and 5 years were 15.1% and 25.1%, respectively. The mortality risk was significantly higher in patients with out-of-hospital rebleeding episodes than in those without (hazard ratio, 1.42). Of the 30 factors, multivariate analysis showed that shock index ≥1 (subdistribution hazard ratio [SHR], 1.25), blood transfusion (SHR, 1.26), in-hospital rebleeding (SHR, 1.26), colonic diverticular bleeding (SHR, 2.38), and thienopyridine use (SHR, 1.24) were significantly associated with increased rebleeding risk. Multivariate analysis of colonic diverticular bleeding patients showed that blood transfusion (SHR, 1.20), in-hospital rebleeding (SHR, 1.30), and thienopyridine use (SHR, 1.32) were significantly associated with increased rebleeding risk, whereas endoscopic hemostasis (SHR, 0.83) significantly decreased the risk.
These large, nationwide follow-up data highlighted the importance of endoscopic diagnosis and treatment during hospitalization and the assessment of the need for ongoing thienopyridine use to reduce the risk of out-of-hospital rebleeding. This information also aids in the identification of patients at high risk of rebleeding.